Charlotte A Lanteri
Overview
Explore the profile of Charlotte A Lanteri including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
28
Citations
715
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Zurawski D, Serio A, Black C, Pybus B, Akers K, Deck D, et al.
Mil Med
. 2023 Nov;
189(5-6):e1353-e1361.
PMID: 37963013
Introduction: Combat-related wound infections complicate the recovery of wounded military personnel, contributing to overall morbidity and mortality. Wound infections in combat settings present unique challenges because of the size and...
2.
Richard S, Pollett S, Fries A, Berjohn C, Maves R, Lalani T, et al.
JAMA Netw Open
. 2023 Jan;
6(1):e2251360.
PMID: 36652247
Importance: Understanding the factors associated with post-COVID conditions is important for prevention. Objective: To identify characteristics associated with persistent post-COVID-19 symptoms and to describe post-COVID-19 medical encounters. Design, Setting, And...
3.
Ellis G, Lanteri C, Hsieh H, Graf P, Pineda G, Crum-Cianflone N, et al.
Emerg Infect Dis
. 2022 Aug;
28(9):1842-1846.
PMID: 35997543
We conducted a retrospective cohort study that tested 2,000 US military personnel for Coccidioides antibodies in a disease-endemic region. The overall incidence of seroconversion was 0.5 cases/100 person-years; 12.5% of...
4.
Richard S, Pollett S, Lanteri C, Millar E, Fries A, Maves R, et al.
Open Forum Infect Dis
. 2021 Dec;
8(12):ofab556.
PMID: 34909439
Background: We evaluated clinical outcomes, functional burden, and complications 1 month after coronavirus disease 2019 (COVID-19) infection in a prospective US Military Health System (MHS) cohort of active duty, retiree,...
5.
Lu Z, Laing E, Pena DaMata J, Pohida K, Tso M, Samuels E, et al.
J Infect Dis
. 2021 Oct;
224(12):2010-2019.
PMID: 34673956
Background: Characterizing the longevity and quality of cellular immune responses to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) enhances understanding of coronavirus disease 2019 (COVID-19) immunity that influences clinical outcomes....
6.
Hall M, Anderson J, Anderson A, Baker D, Bradner J, Brimacombe K, et al.
J Infect Dis
. 2021 Jun;
224(Supplement_1):S1-S21.
PMID: 34111271
The NIH Virtual SARS-CoV-2 Antiviral Summit, held on 6 November 2020, was organized to provide an overview on the status and challenges in developing antiviral therapeutics for coronavirus disease 2019...
7.
Shrestha B, Shah Z, Morgan A, Saingam P, Chaisatit C, Chaorattanakawee S, et al.
J Infect Dis
. 2021 Feb;
224(6):1077-1085.
PMID: 33528566
Background: Newly emerged mutations within the Plasmodium falciparum chloroquine resistance transporter (PfCRT) can confer piperaquine resistance in the absence of amplified plasmepsin II (pfpm2). In this study, we estimated the...
8.
Chaorattanakawee S, Lon C, Chann S, Thay K, Kong N, You Y, et al.
Malar J
. 2017 Oct;
16(1):392.
PMID: 28964258
Background: While intensive Plasmodium falciparum multidrug resistance surveillance continues in Cambodia, relatively little is known about Plasmodium vivax drug resistance in Cambodia or elsewhere. To investigate P. vivax anti-malarial susceptibility...
9.
Agrawal S, Moser K, Morton L, Cummings M, Parihar A, Dwivedi A, et al.
J Infect Dis
. 2017 Sep;
216(4):468-476.
PMID: 28931241
Background: Amplified copy number in the plasmepsin II/III genes within Plasmodium falciparum has been associated with decreased sensitivity to piperaquine. To examine this association and test whether additional loci might...
10.
Farmer A, Lanteri C, Steele E, Mende K, Pamplin J, Akers K
Mil Med
. 2017 Sep;
182(9):e1779-e1784.
PMID: 28885937
Introduction: The Nanosphere Verigene Blood Culture Nucleic Acid Tests allow pathogen and antimicrobial resistance marker identification within 2.5 hours of a positive blood culture. This study assessed the sensitivity of...